We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+19.39%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$875B
AUM Growth
+$257B
Cap. Flow
+$13B
Cap. Flow %
1.48%
Top 10 Hldgs %
22.67%
Holding
15,445
New
2,573
Increased
6,088
Reduced
4,803
Closed
1,873

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.91B
2
SPCX
SpaceX
SPCX
+$871M
3
LLY icon
Eli Lilly
LLY
+$719M
4
AMZN icon
Amazon
AMZN
+$698M
5
NFLX icon
Netflix
NFLX
+$627M

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.67%
2 Technology 3.92%
3 Healthcare 2.55%
4 Industrials 2.24%
5 Financials 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAUT icon
13201
CALL
Nautilus Biotechnolgy
NAUT
$113M
$35.2K ﹤0.01%
+18,800
New +$49.6K
EBON icon
13202
Ebang International Holdings
EBON
$12.6M
$35.1K ﹤0.01%
+16,081
New +$35.3K
GRO
13203
CALL
Brazil Potash Corp
GRO
$145M
$35K ﹤0.01%
+16,300
New +$44.1K
CRDL
13204
CALL
Cardiol Therapeutics
CRDL
$216M
$34.8K ﹤0.01%
32,800
-43,800
-57% -$55.4K
TRON
13205
CALL
Tron Inc
TRON
$669M
$34.3K ﹤0.01%
21,300
-147,100
-87% -$297K
SSP icon
13206
E.W. Scripps
SSP
$297M
$34.2K ﹤0.01%
12,352
-335,313
-96% -$1.27M
ATYR
13207
PUT
aTyr Pharma
ATYR
$38.2M
$34.1K ﹤0.01%
57,200
+9,400
+20% +$6.14K
GHG
13208
GreenTree Hospitality
GHG
$104M
$34.1K ﹤0.01%
30,195
-15,643
-34% -$18.8K
AQB icon
13209
AquaBounty Technologies
AQB
$5.66M
$34.1K ﹤0.01%
31,880
-2,148
-6% -$2.09K
SYPR icon
13210
CALL
Sypris Solutions
SYPR
$40.1M
$34K ﹤0.01%
+14,000
New +$43.4K
VTGN icon
13211
CALL
VistaGen Therapeutics
VTGN
$10.5M
$33.7K ﹤0.01%
149,000
-90,200
-38% -$54.4K
COSM icon
13212
CALL
Cosmos Holdings
COSM
$27.9M
$33.6K ﹤0.01%
182,100
-114,200
-39% -$33.2K
ORGN
13213
DELISTED
Origin Materials
ORGN
$33.5K ﹤0.01%
33,828
+20,773
+159% +$33.8K
CHMI
13214
CALL
Cherry Hill Mortgage Investment Corp
CHMI
$105M
$33.4K ﹤0.01%
14,400
-17,800
-55% -$44.5K
VUZI icon
13215
Vuzix
VUZI
$214M
$33.4K ﹤0.01%
11,518
-440,200
-97% -$1.39M
PRT
13216
PermRock Royalty Trust Unit
PRT
$25.7M
$32.9K ﹤0.01%
+14,675
New +$37.4K
MCRP
13217
Micropolis AI Robotics
MCRP
$28M
$32.8K ﹤0.01%
+17,910
New +$42.9K
BBLG
13218
Bone Biologics
BBLG
$1.49M
$32.7K ﹤0.01%
+23,879
New +$31.2K
HUDI icon
13219
Huadi International Group
HUDI
$10.7M
$32.7K ﹤0.01%
+35,556
New +$38.9K
CMCM
13220
Cheetah Mobile
CMCM
$92.5M
$32.6K ﹤0.01%
+10,781
New +$51.3K
SQFT icon
13221
Presidio Property Trust
SQFT
$1.91M
$32.5K ﹤0.01%
+13,268
New +$39.3K
YQ
13222
17 Education & Technology Group
YQ
$32.4M
$32.5K ﹤0.01%
14,764
+4,328
+41% +$9.73K
MNDR
13223
Mobile-health Network Solutions
MNDR
$1.7M
$32.5K ﹤0.01%
+10,613
New +$51.9K
BEEM icon
13224
PUT
Beam Global
BEEM
$31.2M
$32.4K ﹤0.01%
24,900
+9,900
+66% +$15.2K
IPM
13225
Intelligent Protection Management Corp
IPM
$23.9M
$32.3K ﹤0.01%
+18,548
New +$33.7K

Similar funds

Citadel Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.

  • Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
  • Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
  • Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
  • Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
  • Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
  • Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.